IL-37基因启动子的克隆及其荧光素酶报告基因载体的构建

[目的]克隆白介素-37(IL-37)基因启动子,构建其荧光素酶报告基因载体,并分析活性。[方法]用PCR方法扩增IL-37基因5'端上游区3个不同长度的启动子片段,分别克隆入荧光素酶报告基因载体p GL3,构建IL-37基因启动子荧光素酶报告基因质粒。将所构建的质粒转染HEK-293细胞,通过双荧光素酶报告基因系统分析启动子的转录活性。[结果]754、1 017、2 043 bp等3个IL-37启动子片段正确亚克隆入荧光素酶报告基因载体,重组质粒转染HEK-293细胞后,双荧光素酶活性分析显示1 017 bp的启动子片段具有较强转录活性,约为对照组(空载体p GL3-basic)的10.9倍。[结论]成功克隆IL-37基因启动子,构建了大小为1 017 bp的IL-37基因启动子荧光素酶报告基因载体,为IL-37表达的调控机制的研究提供有效的工具。     

紫杉醇调节TIMP-1启动子活性及TIMP-1降低紫杉醇对乳腺癌细胞增殖抑制作用的研究

目的 探讨TIMP-1在降低MCF-7对紫杉醇敏感性中的作用。方法 采用DNA重组技术构建含timp-1基因启动子的荧光素酶报告质粒并瞬时转染MCF-7细胞,在撤血清条件下测定荧光素酶的相对活性,以验证重组质粒的有效性;重组质粒瞬时转染入MCF-7细胞中,经紫杉醇处理后,测定荧光素酶的相对表达活性;检测在紫杉醇作用下,TIMP-1过表达克隆与对照克隆细胞增殖的情况。结果 酶切、PCR及测序鉴定结果证实成功构建带有TIMP-1启动子的报告基因表达质粒;且撤血清条件下TIMP-1启动子转录活性显著增强,1000nmol／L紫杉醇处理的MCF-7细胞中TIMP-1启动子调控的荧光素酶活性显著降低;紫杉醇对TIMP-1过表达克隆的细胞增殖抑制作用显著低于对照克隆。结论 成功地构建了含timp-1基因启动子的荧光素酶报告质粒,准确地评价TIMP-1启动子在紫杉醇作用过程中的活性变化,并进一步阐明TIMP-1在降低乳腺癌细胞对紫杉醇敏感性中的作用。     

含G0S2基因启动子的荧光素酶报告基因载体的构建

目的:克隆人G0S2基因启动子并构建荧光素酶报告基因载体,为进一步研究G0S2基因转录调控提供质粒。方法:利用PCR技术从人胚肾293A细胞基因组DNA中克隆获得G0S2基因启动子的DNA片段,将其克隆至pGL3-basic表达载体中,并转化人大肠杆菌DH5α,经限制性内切酶酶切、PCR及测序鉴定得到确认;将重组载体质粒与半乳糖苷酶表达质粒psV-β-Galactosidase共转染至大鼠血管平滑肌细胞(VSMC),检测细胞中荧光素酶的活性。结果:pGL3-G0S2-Promoter重组质粒插入片段和相邻序列正确,克隆的G0S2基因片段有启动子活性(P0.05)。结论:成功构建了pGL3-G0S2-Promoter报告基因质粒,为进一步研究G0S2基因的表达奠定了基础。     

质粒拯救法克隆细菌基因组大片段

[目的]细菌基因组大片段尤其是基因簇的克隆与操作,是细菌基因功能分析的一个难点.基因组测序工作的不断完成和序列信息的大量积累,为细菌基因组:DNA的操作提供了方便.本文报道了利用细菌的全基因组信息和质粒拯救法的原理建立的一种克隆细菌基因组大片段的方法.[方法]首先,根据基因组序列信息,在待克隆片段的一侧扩增一段DNA,并将其克隆到自杀载体上构建打靶质粒,然后,将打靶质粒整合到细菌的基因组中构建重组菌,提取重组菌的基因组DNA,酶切,自连,转化,将自杀质粒与待克隆的目的片段一起拯救出来.最后,根据需要将拯救的DNA片段亚克隆到新的载体中.[结果]我们利用该方法克隆了布鲁氏菌中长度为11kb的virB操纵子,并构建了互补质粒.将该质粒导入到virB的突变株中后使virB操纵子的转录活性得到了恢复,表明该策略切实可行.[结论]这种重组克隆策略给我们提供了一种新的对细菌基因组大片段进行操作的方法.     

含VEGF启动子的报告基因的构建及雌激素受体对其活性的影响

目的：构建含血管内皮生长因子（VEGF）基因启动子的荧光素酶报告基因载体,并检测其在雌激素受体作用下的转录活性。方法：以乳腺癌细胞系MCF-7基因组为模板,扩增VEGF启动子片段,克隆到荧光素酶报告基因载体pGL3-basic中。用脂质体介导的基因瞬时转染法,将重组正确的报告基因载体转染293T细胞,检测重组质粒中荧光素酶报告基因的表达。结果：酶切鉴定和DNA序列分析表明构建了正确的pGL3-basic—VEGF报告基因载体;转录活性实验表明构建的报告基因载体具有启动子活性,雌激素受体α（ERα）能以剂量依赖的方式升高VEGF启动子调控下的报告基因的转录。结论：克隆了VEGF启动子,为ERα共调节子的功能研究奠定了基础。     

FLT-1启动子荧光素酶报告基因重组体的构建和鉴定

目的：为探索FLT-1启动子靶向调控活性分析,克隆FLT-1启动子基因序列,构建并鉴定肿-1启动子调控的荧光素酶报告基因重组体pGL3-FLT—Basic—luc。方法：应用聚合酶链式反应（PCR）技术扩增FLT-1启动子序列,定向亚克隆至荧光素酶表达载体pGL3-Basic—luc中,构建含有正确目的基因的报告基因重组体pGL3-FIT—Basic—luc,通过限性内切酶酶切、PCR及测序进行鉴定。结果：通过酶切鉴定及基因测定证明,所克隆的基因产物与预期结果-致,序列无碱基突变。结论：成功构建了含有FLT-1启动子基因序列的荧光素酶报告基因真核表达载体,为下-步分析该启动子活性及血管疾病的基因治疗奠定基础。     

人Cuedc2启动子区的克隆与鉴定

目的:克隆并鉴定和分析人Cuedc2启动子,为进一步研究其转录调控机制和功能提供实验基础。方法:对Cuedc2基因翻译起始位点上游约2000bp的序列进行在线生物信息学分析,使用PCR技术扩增该序列并测序,将扩增获得的该片段定向克隆入PGL-3basic载体中,构建荧光素酶报告基因质粒Cuedc2-luc。荧光素酶分析检测启动子的活性。结果:本实验成功构建了含有Cuedc2基因启动子序列的荧光报告系统,经体外验证该报告基因重组载体具有转录活性。结论:本实验所构建的Cuedc2基因启动子报告基因载体,为进一步研究Cuedc2基因的转录调控及其功能奠定了基础。     

EphA3基因启动子区域定位表达及活性分析

目的构建含有不同长度EphA3基因启动子片段的报告基因载体,研究其在293T细胞和MEF细胞中的转录活性。方法以Balb／C小鼠基因组DNA为模板,扩增不同长度的EphA3基因启动子片段,并克隆进入荧光素酶报告基因质粒pGL3-Basic真核表达载体内。酶切鉴定及基因测序无误后,将重组质粒和pRL—CMV内对照质粒共转染293T和MEF细胞,分析不同长度的OhA3基因启动子片段的转录活性。结果酶切和测序鉴定表明表达载体构建成功,EphA3基因的核心启动子区域位于-279bp～＋110bp之间,在293T细胞和MEF细胞中其转录活性相似。结论成功构建了荧光素报告基因重组质粒,并确定了BphA3基因的核心启动子区域。     

人肝癌细胞LASP1 启动子的克隆及其核心调控区域的初步鉴定

目的:克隆人肝癌细胞的LASP1基因的启动子区域并找出该基因启动子的核心调控区域。方法:提取肝癌Hep G2细胞总DNA,PCR扩增不同长度的LASP1启动子片段,克隆至PGL3-Basic载体中构建重组表达载体PGL3-P1(2059 bp)、PGL3-P2(1123bp)、PGL3-P3(909 bp)、PGL3-P4(574 bp)和PGL3-P5(159 bp),转化入大肠埃希菌(E.coli)DH5α中,提取质粒经双酶切、PCR及测序鉴定阳性克隆并测序。将构建的重组表达载体、PGL3-Basic载体分别与内参质粒PRL-Tk共转染Hep G2细胞,48 h后经双荧光素酶报告基因检测试剂盒检测其活性。结果:PCR结果、双酶切结果以及DNA测序结果表明成功构建了LASP1启动子荧光素酶报告基因载体;双荧光素酶报告基因检测结果显示,与PGL3-Basic组相比,重组载体PGL3-P1、PGL3-P2、PGL3-P3、PGL3-P4均具有较强的启动子活性(P0.01),其中,PGL3-P4的活性最强。结论:成功构建了人肝癌细胞不同截断长度的LASP1基因启动子荧光素酶报告基因载体,确定了LASP-1基因启动子的核心区域(-581 bp~-8 bp),为进一步研究LASP1基因在肝癌细胞中表达的关键调节因素及分子机制奠定了基础。     

小鼠TIE2基因启动子的克隆及转录活性分析

克隆小鼠TIE2基因的启动子并分析其转录活性.设计并合成引物,以小鼠肝脏组织DNA为模板,巢式PCR扩增小鼠TIE2基因启动子区.将扩增获得的系列截短片段克隆入荧光素酶(Luc)报告基因表达载体pGL3-Basic中,构建系列启动子区转录活性报告质粒pGL3-TIE2-Luc.报告质粒与内参质粒共转染SVEC4-10、NIH3T3、HUVEC及NIT-1细胞系,48h后收获细胞检测双荧光素酶的表达情况.构建的pGL3-TIE2-Luc系列报告质粒经过酶切鉴定及DNA测序分析都显示正确;转染4种细胞系后进行双荧光素酶活性检测的结果表明,TIE2基因启动子区域(-2056-+1)具有较强的转录活性.成功构建小鼠TIE2基因启动子报告质粒,证实TIE2基因上游区域(-2056-+1)具有较强的启动子活性.     

布鲁氏菌2308ery基因启动子缺失株的构建及鉴定

目的:构建布鲁氏菌2308株ery基因启动子缺失株。方法:用PCR方法从亲本株2308上扩增ery基因启动子侧翼序列,将该片段与pMD19-T连接,亚克隆为自杀载体pGEM-7zf-Δery-sacB。将自杀载体电转化布鲁氏菌感受态细胞中经同源重组后,分别用100 mg/L氨苄和7%蔗糖筛选。对获得的基因缺失株进行RT-PCR鉴定和遗传稳定性检测。结果:成功获得ery基因启动子缺失株,2308Δery基因启动子缺失株未扩增出eryA基因。并且该缺失株在10代以内未发生回复突变。结论:成功构建2308Δery基因启动子缺失株,为研究布鲁氏菌的毒力基因及其流产机制奠定基础。     

Genetic complementation analysis of the Agrobacterium tumefaciens virB operon: virB2 through virB11 are essential virulence genes.

The Agrobacterium tumefaciens virB gene products are proposed to assemble into a transport system capable of exporting complexes of DNA and protein across the bacterial envelope en route to plant cells. Nonpolar null mutations were constructed in each of the 11 virB genes of the A. tumefaciens pTiA6NC plasmid. In tumorigenicity assays, delta virB1 mutants exhibited severely attenuated virulence and delta virB2 through delta virB11 mutants exhibited avirulence. NdeI restriction sites introduced at the predicted translational start sites of the virB genes were used to subclone each of the virB genes downstream of the lacZ or virB promoter on broad-host-range plasmids. virB gene expression plasmids were used to define promoter and general sequence requirements for genetic complementation of the deletion mutations. Whereas virB1 and virB2 complemented delta virB1 and delta virB2, respectively, only when expressed in trans from the virB promoter, virB3 through virB11 complemented the corresponding deletion mutations when expressed in trans from either the lacZ or virB promoter. Several virB genes required additional upstream or downstream sequences for complementation: (i) virB2 complemented the delta virB2 mutation only when the complementing plasmid coexpressed virB1 and virB2, (ii) virB6 and virB9 complemented the delta virB6 and delta virB9 mutations only when the complementing plasmids carried at most 55 and 230 bp of sequences residing 5' of these genes, respectively, and (iii) virB7 and virB8 complemented the delta virB7 and delta virB8 mutations only when the complementing plasmid coexpressed virB7 and virB8. These studies established that virB1 is an accessory virulence determinant and virB2 through virB11 are absolutely essential for the A. tumefaciens infection process.     

产朊假丝酵母整合表达载体的构建

[目的]构建一个产朊假丝酵母(Candida utilis,C.utilis)整合表达载体.[方法]该载体以质粒pBR322为骨架,包括3-磷酸甘油醛脱氢酶(GAP)启动子和终止子、放线菌酮(CYH)抗性基因和18S rDNA介导的同源整合区.再以木聚糖酶基因为目标基因,插入pGLR9K载体上,构建重组表达载体,电击转化C.utilis.对阳性转化子进行酶活测定,检测其表达情况.[结果]转化子的胞内外都可检测到木聚糖酶酶活,酶活可达60 U/mL.[结论]本实验构建了一个C.utilis载体,并用此载体表达了木聚糖酶基因,本研究将为产朊假丝酵母工程菌在饲料添加剂及食品行业中的应用提供又一个新的实验平台.     

2308、M28、S1330、16M四株布鲁氏菌灭活参数研究

【目的】比较不同灭活方法对布鲁氏菌灭活的效果,确定灭活参数,为制备布鲁氏菌灭活抗原提供参考。【方法】将4株布鲁氏菌参考强毒株2308(牛种)、M28(羊种)、S1330(猪种)以及16M(羊种)分别经大豆酶消化蛋白胨(TSA)培养基培养繁殖后,用生理盐水制成(4-8)×1010 CFU/m L的菌悬液,分成等份于80 oC灭活不同时间,另将同样浓度的菌悬液分别用不同浓度甲醛于37 oC灭活不同时间,通过灭活检验,确定灭活效果。取经甲醛和热灭活的16M抗原,分别以1×1010 CFU/只剂量皮下注射1.5-2.0 kg家兔2只,免疫6周内,每周采血用虎红平板凝集试验(RBT)和试管凝集试验(SAT)测定抗体效价。【结果】80 oC、5 min可灭活2308、S1330和16M三种菌株,80 oC、10 min可灭活全部4种菌株。0.2%甲醛灭活7 d,4种试验菌株均不能被彻底灭活;0.4%甲醛在12 h内只能灭活16M,72 h可灭活M28;0.4%甲醛灭活2308和S1330两次试验结果差异较大。0.6%甲醛可在72 h内灭活4种试验菌。不同方法灭活的16M抗原免疫家兔后,其血清抗体虎红平板凝集和试管凝集效价消长趋势基本一致,甲醛灭活的抗原免疫原性略高于热灭活抗原。【结论】80 oC热灭活和0.6%甲醛灭活均可用于对布鲁氏菌的灭活,且不影响布鲁氏菌的免疫原性。     

Complementation analysis of Agrobacterium tumefaciens Ti plasmid virB genes by use of a vir promoter expression vector: virB9, virB10, and virB11 are essential virulence genes.

The virB gene products of the Agrobacterium tumefaciens tumor-inducing (Ti) plasmid have been proposed to mediate T-DNA transport through the bacterial cell wall into plant cells. Previous genetic analysis of the approximately 9.5-kilobase-pair virB operon has been limited to transposon insertion mutagenesis. Due to the polarity of the transposon insertions, only the last gene in the operon, virB11, is known to provide an essential virulence function. We have now begun to assess the contribution of the other virB genes to virulence. First, several previously isolated Tn3-HoHo1 insertions in the 3' end of the virB operon were precisely mapped by nucleotide sequence analysis. Protein extracts from A. tumefaciens strains harboring these insertions on the Ti plasmid were subjected to immunostaining analysis with VirB4-, VirB10-, and VirB11-specific antisera to determine the effect of the insertion on virB gene expression. In this manner, avirulent mutants containing polar insertions in the virB9 and virB10 genes were identified. To carry out a complementation analysis with these virB mutants, expression vectors were constructed that allow cloned genes to be expressed from the virB promoter in A. tumefaciens. These plasmids were used to express combinations of the virB9, virB10, and virB11 genes in trans in the virB insertion mutants, thereby creating strains lacking only one of these three virB gene products. Virulence assays on Kalanchoe daigremontiana demonstrated that in addition to virB11, the virB9 and virB10 genes are required for tumorigenicity.     

A homologue of an operon required for DNA transfer in Agrobacterium is required in Brucella abortus for virulence and intracellular multiplication

As part of a Brucella abortus 2308 genome project carried out in our laboratory, we identified, cloned, and sequenced a genomic DNA fragment containing a locus (virB) highly homologous to bacterial type IV secretion systems. The B. abortus virB locus is a collinear arrangement of 13 open reading frames (ORFs). Between virB1 and virB2 and downstream of ORF12, two degenerated, palindromic repeat sequences characteristic of Brucella intergenic regions were found. Gene reporter studies demonstrated that the B. abortus virB locus constitutes an operon transcribed from virB1 which is turned on during the stationary phase of growth. A B. abortus polar virB1 mutant failed to replicate in HeLa cells, indicating that the virB operon plays a critical role in intracellular multiplication. Mutants with polar and nonpolar mutations introduced in virB10 showed different behaviors in mice and in the HeLa cell infection assay, suggesting that virB10 per se is necessary for the correct function of this type IV secretion apparatus. Mouse infection assays demonstrated that the virB operon constitutes a major determinant of B. abortus virulence. It is suggested that putative effector molecules secreted by this type IV secretion system determine routing of B. abortus to an endoplasmic reticulum-related replication compartment.     

人类诺如病毒反向遗传体系的构建与验证

为验证已报道的能复制人类诺如病毒(human norovirus,HuNoV)GⅡ.3 U201感染性克隆的复制能力,进一步在HuNoV临床病毒株中寻找更优序列,构建能高效复制的感染性克隆,本研究合成含有T7启动子和EF­1α启动子的HuNoV GⅡ.3 U201全长序列,构建质粒pU201和pEF­1α­U201及对应的病毒RNA聚合酶失活的突变质粒。在COS 7细胞和Huh 7细胞中分别共转染T7聚合酶与pU201以及单独转染pEF­1α­U201,利用实时荧光定量聚合酶链反应检测转染后不同时间点细胞内病毒RNA水平。结果显示,与对照组相比,pU201和pEF­1α­U201的病毒RNA水平升高约2倍和3倍。为便于检测HuNoV复制,在pU201和pEF­1α­U201质粒中分别插入NanoLuc™荧光素酶报告基因,并命名为pU201­Nluc和pEF­1α­U201­Nluc。将质粒分别转染COS 7细胞和Huh 7细胞,检测转染后不同时间点Nluc荧光素酶活性。结果显示,pEF­1α­U201­Nluc的Nluc荧光素酶活性相较于对照组增高近2倍,而pU201­Nluc无明显升高,提示EF­1α启动子起始病毒复制优于T7启动子。为寻找优于HuNoV GⅡ.3 U201的HuNoV序列,合成HuNoV GⅡ.4临床病毒株全长序列,将其插入EF­1α启动子载体中并转染细胞,于不同时间点检测上清及细胞中病毒RNA水平。结果显示,上清及细胞中病毒RNA水平与对照组相比无显著差异。以上结果提示,已报道可复制的HuNoV GⅡ.3 U201反向遗传体系复制效率有限,且HuNoV反向遗传体系复制能力可能与不同序列的病毒相关。     

A ColE1-compatible expression vector for the production of His-tagged fusion proteins

Plasmid pDB31 is a ColE1-compatible expression vector based on the p15A origin of replication. It is designed to express His-tagged fusion proteins in cells co-hosting a compatible expression vector. It was constructed by assembling the operator/promoter region plus the 6xHis and the multiple cloning site of pQE31 (QIAGEN) with the p15A origin of replication plus Kan^R of pGP1-2. The plasmid was found to be stable in Escherichia coli strains BL21 and DH11S. It was used to produce and purify the ferredoxin reductase component of Comamonas testosteroni B-356 biphenyl dioxygenase inside a clone hosting the remaining dioxygenase genes on a compatible plasmid.